Function and clinical potential of miRNA-29 family in thoracic aortic aneurysm

Abstract

Thoracic aortic aneurysm (TAA) represents the 15th leading cause of death in patients greater than 65 years (1). The incidence of TAA is estimated to be around 10 per 100,000 person-years and is approximately equal in men and women (2).